Chargement en cours...
Ethics framework for treatment use of investigational drugs
BACKGROUND: Expanded access is the use of investigational drugs (IDs) outside of clinical trials. Generally it is performed in patients with serious and life-threatening diseases who cannot be treated satisfactorily with authorized drugs. Legal regulations of expanded access to IDs have been introdu...
Enregistré dans:
| Publié dans: | BMC Med Ethics |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7672838/ https://ncbi.nlm.nih.gov/pubmed/33208140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12910-020-00560-9 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|